In the book, “Outlive,” Peter Attia refers to neurodegenerative diseases, such as Alzheimer’s and dementia, as one of the “Four Horsemen” of chronic diseases that significantly impacts human longevity and the experience of aging. This blog post explores the Alzheimer's research and treatment landscape, culminating in the recent approval of...
Read More
The COVID-19 pandemic acted as a catalyst for the widespread adoption of telehealth. Initially driven by necessity, virtual care rapidly became an...
Technological innovation has had an immense impact on healthcare delivery. Novel medical devices and cutting-edge pharmaceuticals continue to...
The escalating cost of prescription drugs has become a pressing concern for patients, healthcare providers, and policymakers alike. In this landscape...
Medicare Advantage has been facing criticism for its administrative and financial delays, and an increasing number of hospitals are scrapping their...
In April 2022, the FDA released draft guidance with recommendations for drug developers and clinical trial researchers. The guidance highlights gaps...
Rare Disease Day will take place on February 29th this year and is a global opportunity to raise awareness for the individuals and families facing...
In the ever-evolving landscape of healthcare, a challenge persists – the unequal distribution, access, and quality of care for individuals. In...
Therapeutic innovation drives patient treatment updates and improves patient outcomes. From the development of chemotherapy to monoclonal antibody...
Payors are major stakeholders in the US healthcare system and shape patient access, health spending, and reimbursement. In this blog post, we will...
